Views & Analysis Better customer engagement: Is your data letting you down? The pressure is on for better quality, more granular customer data.
Views & Analysis Behind the buzz of real-world data and real-world evidence Putting the who, where and why of real-world studies into context.
Views & Analysis Web and mobile technologies for health economics modelling Digital apps are more agile than longstanding solutions and allow tailored interrogation of data.
Views & Analysis Tracking studies: moving with the times Awareness, Trial, and Usage tracking can be enhanced if technology updates it in real time.
Views & Analysis Data: underpinning health R&D Big data initiatives positioning the UK as a desirable location for R&D.
Views & Analysis The biggest NHS deficit: not money but data Information gleaned from data is the key to making health services safer, more efficient and cost effective.
News GSK gets second cancer drug approval from Nuvalent buy The FDA has cleared GSK's ALK inhibitor Nelkarmi for a form of lung cancer, the second product from its $10.6bn acquisition of Nuvalent.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.